Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists
Takashi Nagahara, Tsuyoshi Saitoh, Noriki Kutsumura, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 20, pp. 7931-7937
Closed Access | Times Cited: 109

Showing 26-50 of 109 citing articles:

The present and future of synthetic orexin receptor agonists
Tsuyoshi Saitoh, Takeshi Sakurai
Peptides (2023) Vol. 167, pp. 171051-171051
Open Access | Times Cited: 13
Expression and purification of an activated Orexin receptor 1- G-protein complex
Ioanna Ramou, Steven Janvier, Sarah Druwé, et al.
Protein Expression and Purification (2025) Vol. 228, pp. 106660-106660
Closed Access
Alluring Potential to Accelerate Emergence and Ameliorate Opioid-induced Respiratory Depression without Antagonizing Analgesia: Danavorexton Enters the Anesthetic Landscape
Toshihiro Imamura, Max B. Kelz
Anesthesiology (2025) Vol. 142, Iss. 4, pp. 589-592
Closed Access
Management of Narcolepsy
Lucie Barateau, Régis Lopez, Yves Dauvilliers
Current Treatment Options in Neurology (2016) Vol. 18, Iss. 10
Closed Access | Times Cited: 45
Orexin supplementation in narcolepsy treatment: A review
Eugenie Nepovimová, Jana Janočková, Jan Misík, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 3, pp. 961-975
Closed Access | Times Cited: 41
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
Michelle Cao, Matthew Chow
Nature and Science of Sleep (2016), pp. 81-81
Open Access | Times Cited: 38
The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders
Christoph Boss, John Gatfield, Christine Brotschi, et al.
ChemMedChem (2020) Vol. 15, Iss. 23, pp. 2286-2305
Closed Access | Times Cited: 37
The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment
Lucie Barateau, Roland Liblau, Christelle Peyron, et al.
CNS Drugs (2017) Vol. 31, Iss. 10, pp. 821-834
Closed Access | Times Cited: 36
Orexin OX2 Receptor Antagonists as Sleep Aids
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies
Hiroshi Nagase, Naoshi Yamamoto, Masahiro Yata, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1018-1040
Closed Access | Times Cited: 34
Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions
Alexander Heifetz, Matteo Aldeghi, Ewa I. Chudyk, et al.
Biochemical Society Transactions (2016) Vol. 44, Iss. 2, pp. 574-581
Open Access | Times Cited: 32
Neural circuitry underlying REM sleep: A review of the literature and current concepts
Yi‐Qun Wang, Wenying Liu, Lei Li, et al.
Progress in Neurobiology (2021) Vol. 204, pp. 102106-102106
Closed Access | Times Cited: 25
Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists
Dehui� Zhang, David A. Perrey, Ann M. Decker, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8806-8825
Open Access | Times Cited: 23
Isolation, synthesis and medicinal chemistry of biphenyl analogs – A review
Sandeep Singh, P Geetha, R. Ramajayam
Results in Chemistry (2023) Vol. 6, pp. 101135-101135
Open Access | Times Cited: 10
Novel orexin receptor agonists based on arene- or pyridine-fused 1,3-dihydro-2H-imidazole-2-imines
Wentian Wang, Alok Ranjan, Wei Zhang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 99, pp. 129624-129624
Open Access | Times Cited: 3
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
An overview of hypocretin based therapy in narcolepsy
Shinichi Takenoshita, Noriaki Sakai, Yuhei Chiba, et al.
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 4, pp. 389-406
Closed Access | Times Cited: 31
Mapping the Hypocretin/Orexin Neuronal System: An Unexpectedly Productive Journey
Christelle Peyron, Thomas S. Kilduff
Journal of Neuroscience (2017) Vol. 37, Iss. 9, pp. 2268-2272
Open Access | Times Cited: 29
Pharmacologic Management of Excessive Daytime Sleepiness
Shinichi Takenoshita, Seiji Nishino
Sleep Medicine Clinics (2017) Vol. 12, Iss. 3, pp. 461-478
Closed Access | Times Cited: 29
Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction
Coleman B. Calva, Jim R. Fadel
Brain Research (2018) Vol. 1731, pp. 145921-145921
Open Access | Times Cited: 28
The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain
Satoshi Toyama, Naohito Shimoyama, Megumi Shimoyama
Neuropeptides (2016) Vol. 61, pp. 95-100
Closed Access | Times Cited: 27
Nonpeptide Orexin-2 Receptor Agonist Attenuates Morphine-induced Sedative Effects in Rats
Satoshi Toyama, Naohito Shimoyama, Yugo Tagaito, et al.
Anesthesiology (2018) Vol. 128, Iss. 5, pp. 992-1003
Open Access | Times Cited: 27
Current development in sulfonamide derivatives to enable CNS-drug discovery
Klaudia Blicharz-Futera, Michał Kamiński, Katarzyna Grychowska, et al.
Bioorganic Chemistry (2024) Vol. 156, pp. 108076-108076
Closed Access | Times Cited: 2
Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity
Ainoleena Turku, Maiju K. Rinne, Gustav Boije af Gennäs, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0178526-e0178526
Open Access | Times Cited: 22

Scroll to top